Hongrui Liu

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Top Venues

ACS pharmacology & translational science

Applied microbiology and biotechnology

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mengru Li, Fan Cao, Weijie Wang, Yulei Ma, Zhihui Yu, Ke Wang, Ying Chen, Hongrui Liu
Coumarin-Furoxan Hybrid Suppressed the Proliferation and Metastasis of Triple-Negative Breast Cancer by Activating Mitochondrial Stress and Cell Apoptosis. ACS pharmacology & translational science 7 (5) (2024)
Mengru Li, Fan Cao, Weijie Wang, Yulei Ma, Zhihui Yu, Ke Wang, Ying Chen, Hongrui Liu
Coumarin-Furoxan Hybrid Suppressed the Proliferation and Metastasis of Triple-Negative Breast Cancer by Activating Mitochondrial Stress and Cell Apoptosis. ACS pharmacology & translational science 7 (5) (2024)
Yuting Gu, Yilan Shen, Wei Chen, Haidong He, Yulei Ma, Xiaobin Mei, Dianwen Ju, Hongrui Liu
Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response. Applied microbiology and biotechnology 106 (7) (2022)
Zhihui Yu, Mengru Li, Shiqi Guo, Weijie Wang, Feng Qu, Yulei Ma, Hongrui Liu, Ying Chen
Novel Nitric Oxide Donor Dinitroazetidine-Coumarin Hybrids as Potent Anti-Intrahepatic Cholangiocarcinoma Agents. Molecules (Basel, Switzerland) 27 (13) (2022)
Wenjing Zai, Wei Chen, Hongrui Liu, Dianwen Ju
Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications. Biomedicines 9 (12) (2021)
Wenjing Zai, Wei Chen, Jingyun Luan, Jiajun Fan, Xuyao Zhang, Zimei Wu, Tao Ding, Dianwen Ju, Hongrui Liu
Dihydroquercetin ameliorated acetaminophen-induced hepatic cytotoxicity via activating JAK2/STAT3 pathway and autophagy. Applied microbiology and biotechnology 102 (3) (2017)